GlaxoSmithKline PLC (GSK:LSE) Annual Income Statement (GBX)
GSK:LSE Quarterly Financials (GBX)
Frequently Asked Questions About GlaxoSmithKline PLC (GSK:LSE) Stock
GlaxoSmithKline PLC's (GSK:LSE) last reported annual revenue was GBX 30.33 Billion.
GlaxoSmithKline PLC's (GSK:LSE) annual revenue growth rate based on the revenue reported in the past 5 years is : -0.32%
GlaxoSmithKline PLC's(GSK:LSE) is profitable as of its last reported annual financials.
The net profit margin for GlaxoSmithKline PLC's(GSK:LSE) from its laster reported year is 16.25%
The return on equity (ROE) for GlaxoSmithKline PLC's(GSK:LSE) from its last reported annual financials is : N/A
The return on assets (ROA) for GlaxoSmithKline PLC's(GSK:LSE) from its last reported annual financials is : N/A
The return on invested capital (ROIC) for GlaxoSmithKline PLC's(GSK:LSE) from its last reported annual financials is : N/A
The Debt to Equity ratio for GlaxoSmithKline PLC's(GSK:LSE) from its last reported annual financials is : N/A
The dividend yield for GlaxoSmithKline PLC's(GSK:LSE) from its laster reported year is N/A
GlaxoSmithKline PLC's(GSK:LSE) has negative cash flow as of its last reported annual financials.
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Superior total returns
The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.
Superior Earnings Growth
This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.
Superior Dividend Growth
This stock has shown top quartile dividend growth in the previous 5 years compared to its sector
What not to like
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Low Revenue Growth
This stock has shown below median revenue growth in the previous 5 years compared to its sector
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for GSK:LSE !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
